Regioselective synthesis of 3-(heteroaryl)-iminothiazolidin-4-ones

Denis R. St. Laurent(Bristol-Myers Squibb (United States)), Michael H. Serrano‐Wu(Broad Institute), Qi Gao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dedong Wu(Bristol-Myers Squibb (United States))
Tetrahedron Letters
January 23, 2004
10.1016/j.tetlet.2004.01.001
Cited by 52

Related Papers

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196
Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes
|Nature|2019|180
The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
|Journal of Medicinal Chemistry|2014|112
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
|ACS Medicinal Chemistry Letters|2011|86